Related Experiment Video

Updated: Aug 30, 2026

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle
12:19

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle

Published on: June 7, 2024

CpG DNA and cancer immunotherapy: orchestrating the antitumor immune response

James E Wooldridge1, George J Weiner

  • 1Department of Internal Medicine, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, 52242, USA. james-wooldridge@uiowa.edu

Current Opinion in Oncology
|November 19, 2003
PubMed
Abstract

Insights

Synthetic CpG oligonucleotides (CpG DNA) are emerging as a powerful tool in cancer immunotherapy. These agents stimulate the immune system to target and eliminate cancer cells, with ongoing clinical trials showing promising safety and efficacy.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Cancer treatment is increasingly focused on targeted therapies.
  • Harnessing the immune system to fight cancer is a key area of research.
  • Synthetic CpG oligonucleotides (CpG DNA) are novel agents that activate immune responses.

Purpose of the Study:

  • To review the immunologic effects of CpG DNA.
  • To summarize preclinical data on CpG DNA in cancer immunotherapy.
  • To discuss the ongoing clinical development of CpG DNA.

Main Methods:

  • Review of existing literature on CpG DNA.
  • Analysis of preclinical studies in animal cancer models.
  • Examination of early-phase clinical trial data.

Main Results:

  • Three distinct classes of CpG DNA sequences with varying effects have been identified.
  • CpG DNA has demonstrated the ability to induce tumor regression in animal models.
  • CpG DNA acts as a potent vaccine adjuvant, enhancing specific immune responses.

Conclusions:

  • CpG DNA shows significant potential for various applications in cancer immunotherapy.
  • Preclinical findings suggest CpG DNA can activate innate immunity and cellular cytotoxicity.
  • Early clinical trials indicate CpG DNA is safe for human administration, with further research ongoing.

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.